HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

4- bromo- 6- (3- (4- chlorophenyl)propoxy)- 5- (3- pyridylmethylamino)- 3(2H)- pyridazinone hydrochloride

a phosphodiesterase inhibitor, improves claudication-limited exercise performance in patients with peripheral arterial disease
Also Known As:
NM-702; NT 702; NT-702; NT702 cpd; parogrelil hydrochloride
Networked: 3 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Hori, Miyuki: 2 articles (09/2009 - 09/2007)
2. Nakaike, Shiro: 2 articles (09/2009 - 09/2007)
3. Tsuruzoe, Nobutomo: 2 articles (09/2009 - 09/2007)
4. Asakura, Yumiko: 2 articles (09/2009 - 09/2007)
5. Takahashi, Kenzo: 2 articles (09/2009 - 09/2007)
6. Takahashi, Shuya: 2 articles (09/2009 - 09/2007)
7. Kawanishi, Masafumi: 2 articles (09/2009 - 09/2007)
8. Kamon, Junji: 1 article (09/2009)
9. Hoshino, Akihiko: 1 article (09/2009)
10. Iwama, Takehisa: 1 article (09/2009)

Related Diseases

1. Asthma (Bronchial Asthma)
2. Peripheral Arterial Disease
3. Intermittent Claudication

Related Drugs and Biologics

1. 4- bromo- 6- (3- (4- chlorophenyl)propoxy)- 5- (3- pyridylmethylamino)- 3(2H)- pyridazinone hydrochloride